Byterna Therapeutics
PrivateLast Round
Angel
Dec 15, 2025
Total Funding Raised
$4.88M
Company Overview
Byterna Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was an Angel round in December 2025.
Byterna Therapeutics is a biotechnology company that develops circular mRNA (cmRNA) therapeutics for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Byterna Therapeutics Comparables
Compare Byterna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shenzhen MagicRNA Biotechnology Co., Ltd. | 89% | |
| Therorna Inc. | 86% | |
| Suzhou CureMed Biopharma Technology Co., Ltd. | 85% |
For institutional investors. Book with your work email.
Byterna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Dec 15, 2025 | ||||
| Angel | Oct 20, 2025 | ||||
| Grant | Nov 26, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Byterna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Science and Technology Commission of Shanghai Municipality | Grant |
| Beijing Fangfu Venture Capital Management | Angel |
Byterna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Byterna Therapeutics's valuation, stock price, and market status.
Is Byterna Therapeutics a public or private company?
Byterna Therapeutics is a private company.
What is the current stock price of Byterna Therapeutics?
Byterna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Byterna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Byterna Therapeutics worth (valuation)?
Valuation information for Byterna Therapeutics is not publicly available.
Can I buy Byterna Therapeutics stock?
Byterna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Byterna Therapeutics's last funding round?
Byterna Therapeutics's most recent funding round was Angel on December 15, 2025.
Who are the main investors in Byterna Therapeutics?
Key investors in Byterna Therapeutics include Science and Technology Commission of Shanghai Municipality, Beijing Fangfu Venture Capital Management.
Will Byterna Therapeutics IPO soon?
No public IPO plans have been announced for Byterna Therapeutics.
How can I track Byterna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Byterna Therapeutics's shares on secondary markets.